Short Interest & Thesis

Short Interest & Thesis — AUTO1 Group SE (AG1)

Bottom line

Reported short interest is not decision-useful for AG1 today: no official aggregate short-interest series, no daily short-sale-volume series, no public net-short threshold disclosures, and no borrow/securities-lending indicators were staged for this German (Xetra) name. So this page cannot tell a PM whether the position is crowded, hard to borrow, or set up for a squeeze — and it says so plainly rather than dressing up a number that does not exist.

What is decision-useful is the thesis-risk side, and it is built entirely from the primary record. There is no credible public short-seller report or activist campaign in the staged evidence, but there is one real, checkable lever a short would lean on: AG1 now reports positive net income (€78m in FY2025) while its IFRS operating cash flow ran deeply negative (about -€463m in FY2025), because the asset-backed-securitisation (ABS)-funded build of inventory and captive-finance receivables shows up as an operating outflow. Management addresses this directly in its 2026 Capital Markets material. The strongest evidence is the corpus itself (risk factors, the ABS capital structure, management's own cash framing); the biggest gap is the complete absence of positioning and borrow data.

Evidence quality — what exists, what does not

Source: short-interest data availability per staged data/short_interest/ manifest (reported short interest, short-sale volume, disclosures, borrow — all staged as zero rows); EU SSR channel per the staged source manifest.

The staging manifest is explicit: official_reported_short_interest_available is false, every position/volume/disclosure/borrow table is empty, and ADV is null. The only official source the data step even considered for this name was the EU Short Selling Regulation threshold-disclosure channel — which, by construction, captures only holder-level positions above 0.5% of capital and is not a complete aggregate short interest. Treat any later claim that "AG1 short interest is X" with suspicion unless it cites a dated official position report.

Crowding versus liquidity — context, not a verdict

Without shares-short or days-to-cover, AG1 cannot honestly be called "crowded" or "un-crowded." What the price/volume feed does give is the liquidity backdrop a future short-interest read would be judged against.

Source: price, volume and shares-outstanding from the staged numeric feed (data/prices/, data/financials/); ADV and market cap derived from that feed. Last close €24.40 (19 Jun 2026); ~218.8m shares outstanding.

At roughly €24 the stock trades about 36% below its €38.00 February 2021 IPO price, and its ~€5.3bn market cap is well under the ~€7.9bn implied at listing [1]. Average daily turnover of roughly €14m (about 0.75m shares) is moderate for a €5bn name: even a hypothetical short position equal to a few days of float would take many sessions to cover, so if a meaningful short ever showed up, liquidity would amplify rather than cushion a cover. That is a conditional statement — there is no staged short position to apply it to.

One structural caveat on float: only 23.2% of share capital was placed at IPO, with pre-IPO holders (and cornerstones Sequoia Capital and Lone Pine) holding the balance under a 180-day lock-up at the time [1]. A concentrated register tends to mean thinner true free float and thinner lendable supply — a reason borrow data, if it existed, would matter here.

The short-thesis ledger — built from the primary record

There is no staged short-seller report. But a disciplined short case for AG1 would not need one; it would lean on disclosures the company itself makes. Each row below pairs the lever a short would press with what the company's own filings show and how management frames it.

Sources: profit-vs-cash and ABS framing — Capital Markets Event presentation (17 Jun 2026) [8] and [9]; ABS programmes, equity ratio, liquidity-risk and going-concern language — FY2022 Annual Report [2], [4], [5], [6].

The one lever that matters: reported profit versus cash flow

This is the crux of any AG1 short thesis. The numbers are stark.

Source: reported financials, FY2022–FY2025 (data/financials/income.json, cash_flow.json); accumulated deficit and ABS debt cross-read to the FY2022 Annual Report [3].

The widening green-versus-red gap is exactly what a forensic short would screen on: as the model scales, reported earnings improve but IFRS operating cash flow gets more negative, not less, and cash on the balance sheet fell to about €246m at FY2025 from €372m a year earlier. A naive reading says "this company earns profit it cannot collect."

Management's rebuttal is specific and disclosed, not hand-waving: under IFRS the increase in car inventory and captive-finance receivables is booked as an operating cash outflow, while the ABS funding that finances those very assets is booked in financing cash flow — so the operating line overstates the real cash strain [8]. On the company's funded view, inventory growth and captive-finance growth are largely offset by their matched ABS funding.

Source: Capital Markets Event presentation, "AUTO1 has Strong Track Record in Generating Cash" cash bridge (17 Jun 2026) [8].

The institutional read: this is a real unresolved debate, not a fraud flag. The short lever is genuine (IFRS operating cash flow is deeply negative and the model depends on continuously rolling ABS funding to grow), and the rebuttal is genuine too (the funding is matched, non-recourse, and the net exposure is far smaller than the headline outflow). The thesis risk therefore lives in credit/funding-market access, not in an accounting deception — and that is where a PM should focus diligence.

The capital structure a short would attack

Source: reported balance sheet, FY2025 (data/financials/balance_sheet.json); ABS-programme structure and equity-ratio framing per FY2022 Annual Report [2], [4].

AG1's only material financial debt sits in two non-recourse ABS programmes run through dedicated financing companies (AUTO1 Funding B.V. and Autohero Funding 1 B.V.): an inventory ABS facility (€455m drawn at FY2022) secured by the used-car inventory with no further recourse to the group, plus a consumer-loan ABS facility refinancing Autohero instalment receivables [2]. The company itself flags liquidity risk as "the most relevant potential financial risk" and states it will need continued access to banks and capital markets to fund inventory and car loans until it reaches positive operating cash flow [5]. That is the cleanest disclosed bear lever on the page: the model works only as long as the ABS market stays open and cheap.

The mitigants are also in the record. Equity was €685m at FY2022 with a 40.6% equity ratio (down from 56.7%, driven by accumulated losses) [4], and neither management nor the auditor framework identified any risk endangering the company as a going concern — there is no modified or qualified opinion in the readable record [6]. A short thesis built on "going concern" would be contradicted by the primary record; a short thesis built on "ABS-funding fragility in a credit shock" would not.

Where the turnaround cuts against the bears

The disclosed operating trajectory is the single biggest problem for a short. Group adjusted EBITDA swung from -€166m in FY2022 to +€197.5m in FY2025 (a 2.4% margin), and the consolidated loss of €246m in FY2022 has since flipped to reported net profit [3] [7]. A short pressing the cash-flow lever is fighting an improving P&L and a structurally widening unit economics gap (rising gross profit per unit). That asymmetry — improving fundamentals against a funding-structure worry — is precisely why positioning data would be valuable here, and precisely what is missing.

Public net-short disclosure regime — the channel to watch

Source: EU SSR disclosure channel per the staged short-interest source manifest (data/short_interest/source_manifest.json); zero disclosures staged.

AG1 trades on Xetra and falls under the EU SSR. The right place to look for named short holders is the German Federal Gazette (Bundesanzeiger) / BaFin net-short-position publications above the 0.5% threshold. None were staged for this run. The institutional caution: even when populated, that channel shows only large individual positions above the threshold — it is a floor on disclosed shorting, never the full aggregate. Do not let a "no disclosures above 0.5%" reading be mistaken for "no short interest."

Market setup

With no positioning or borrow data, there is no squeeze or forced-de-risking signal to read. The setup risk that is visible is event-driven, not flow-driven: the contested item is the cash-flow narrative, and the catalysts that move it are credit-market conditions (ABS spreads, facility renewals) and each quarterly cash bridge. A short pressing the funding lever is exposed to exactly the upside the bulls own — continued margin expansion and the company's funded-cash-flow framing gaining acceptance — while a long is exposed to a credit-market shock that widens ABS spreads or constrains advance rates. The absence of borrow data means a PM cannot currently size the cost or feasibility of expressing either side via the short leg.

Limitations

This page is deliberately thin on positioning because the positioning data is absent. To be explicit: there is no staged aggregate short interest, no short-sale volume, no public net-short disclosure, no borrow fee/utilisation/lendable-supply data, and no source-dated peer short comparison. ADV is derived from the price feed, not provided. The thesis-risk analysis is grounded in the readable corpus — but note that AG1's own FY2023–FY2025 annual reports and all interim results PDFs in this corpus failed to parse (AES-encrypted), so the most recent disclosed risk-factor and notes language could not be read directly; recent figures lean on the results/Capital Markets presentations and the numeric feed instead. The cleanest next step is to pull the official BaFin/Bundesanzeiger net-short publications and a borrow-cost read before forming any positioning view.